Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by Samyang Biopharmaceuticals Corporation.
Recruitment status was  Recruiting
Information provided by:
Samyang Biopharmaceuticals Corporation Identifier:
First received: January 12, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given